Assessment of tetanus Immunization among healthcare workers in Mogadishu, Somalia.
Healthcare workers
Somalia
tetanus
the survey metod
vaccination
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 12 2023
31 12 2023
Historique:
medline:
28
6
2023
pubmed:
3
5
2023
entrez:
3
5
2023
Statut:
ppublish
Résumé
Tetanus is still a major problem in sub-Saharan African countries. This study aims to evaluate tetanus disease and vaccine awareness among healthcare workers in Mogadishu. This descriptive, cross-sectional study was scheduled for January 2-7, 2022. A questionnaire consisting of 28 questions was applied in a face-to-face manner to 418 healthcare workers. Only health workers aged≥18 living in Mogadishu were included. Questions about sociodemographic characteristics, tetanus disease, and vaccines were developed. 71.1% of the participants were female, 72% were ˂25 years old, 42.6% were nursing students, and 63.2% had a university education. It was observed that 46.9% of the volunteers had an income level of <$250, and 60.8% resided in the city center. 50.5% of the participants received a tetanus vaccine in their childhood. Questions to determine participants' level of knowledge about tetanus and the tetanus vaccine were responded to with an accuracy of between 44 and 77%. Although 38.5% of the participants reported that they were exposed to trauma at least once a day, the rate of those who had three or more doses of the vaccine was only 10.8%. On the other hand, 51.4% reported that they had received training about tetanus and vaccination. There was a significant difference (
Identifiants
pubmed: 37133877
doi: 10.1080/21645515.2023.2202128
pmc: PMC10294765
doi:
Substances chimiques
Tetanus Toxoid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2202128Références
BMC Public Health. 2017 Feb 8;17(1):179
pubmed: 28178973
J Neurochem. 2021 Sep;158(6):1244-1253
pubmed: 33629408
Lancet Glob Health. 2021 Nov;9(11):e1610-e1617
pubmed: 34678200
J Infect Dev Ctries. 2022 Oct 31;16(10):1596-1601
pubmed: 36332212
Vaccines (Basel). 2022 Jun 24;10(7):
pubmed: 35891181
Am J Infect Control. 2011 Aug;39(6):532-3
pubmed: 21601950
Biomed Res Int. 2021 Nov 08;2021:5529315
pubmed: 34790820
Vaccines (Basel). 2022 Dec 21;11(1):
pubmed: 36679864
Int J Equity Health. 2022 Apr 11;21(1):49
pubmed: 35410258
Hum Vaccin Immunother. 2022 Dec 31;18(1):2014732
pubmed: 35172681
Hum Vaccin Immunother. 2020;16(2):349-357
pubmed: 31625792
Sci Prog. 2023 Jan-Mar;106(1):368504221148933
pubmed: 36617884
Front Public Health. 2022 Dec 06;10:1040539
pubmed: 36561858
Acta Chir Orthop Traumatol Cech. 2020;87(4):292-296
pubmed: 32940226
Hum Vaccin Immunother. 2020 May 3;16(5):1181-1188
pubmed: 31567041
Pan Afr Med J. 2019 Jan 09;32:14
pubmed: 31143319
Emerg Med J. 2007 Jun;24(6):417-21
pubmed: 17513539
Vaccine. 2020 Mar 10;38(12):2646-2650
pubmed: 32063435
Biomed Res Int. 2020 May 07;2020:4023031
pubmed: 32461983
Pan Afr Med J. 2017 Jun 22;27(Suppl 3):25
pubmed: 29296160
Glob Health Action. 2019;12(1):1581467
pubmed: 30957685